M. Dobrinska

发表

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

Thomas Layloff, Vinod P. Shah, Kamal K. Midha, 1992 .

The use of stable isotope labeling and liquid chromatography/tandem mass spectrometry techniques to study the pharmacokinetics and bioavailability of the antimigraine drug, MK-0462 (rizatriptan) in dogs.

G. Gatto, T. Olah, M. Dobrinska, 1996, Rapid communications in mass spectrometry : RCM.

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

P. Watkins, E. Kharasch, D. Shen, 2001, Pharmacogenetics.

Biotransformation of sulindac in end‐stage renal disease

R. Davies, J. Lin, M. Dobrinska, 1987, Clinical pharmacology and therapeutics.

Robotic inhibition assay for determination of HMG‐CoA reductase inhibitors in human plasma

B. Matuszewski, M. Dobrinska, Jamie J. Zhao, 2002, Journal of clinical laboratory analysis.

Effect of Increased Inspired Oxygen Concentrations on Exercise Capacity in Stable Heart Failure

M. Mercuri, M. Dobrinska, J. Tobert, 2000 .

An automated sample preparation and high performance liquid chromatographic method for the determination of MK-591, a novel leukotriene biosynthesis inhibitor, in human plasma.

B. Matuszewski, M. Dobrinska, J. Hsieh, 1996, Journal of pharmaceutical and biomedical analysis.

Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys.

M. Dobrinska, A. G. Zacchei, K. C. Kwan, 1982, Drug metabolism and disposition: the biological fate of chemicals.

Pharmacokinetics of 125I‐iothalamate and 131I‐o‐iodohippurate in Man

P. Welling, P. Madsen, M. Dobrinska, 1976, Journal of clinical pharmacology.

Evaluation of Orally Administered Highly Variable Drugs and Drug Formulations

Mario A. González, W. H. Barr, L. Benet, 1996, Pharmaceutical Research.

3-Hydroxy-alpha-methyltyrosine progenitors: synthesis and evaluation of some (2-oxo-1,3-dioxol-4-yl)methyl esters.

C. Sweet, W. S. Saari, S. Gaul, 1984, Journal of medicinal chemistry.

Dosing Considerations and Bioavailability Assessment of Controlled Drug Delivery Systems

P. Welling, M. Dobrinska, 1987 .

Enterohepatic Circulation of Drugs

M. Dobrinska, 1989, Journal of clinical pharmacology.

Pharmacokinetics of methsuximide and a major metabolite in dogs.

P. Welling, M. Dobrinska, 1977, Journal of pharmaceutical sciences.

Determination of simvastatin-derived HMG-CoA reductase inhibitors in biomatrices using an automated enzyme inhibition assay with radioactivity detection.

Rena Zhang, B. Matuszewski, M. Dobrinska, 2003, Journal of pharmaceutical and biomedical analysis.

Fully automated methods for the determination of hydrochlorothiazide in human plasma and urine.

B. Matuszewski, M. Dobrinska, B K Matuszewski, 1994, Journal of pharmaceutical and biomedical analysis.

Enterohepatic circulation of sulindac and metabolites

M. Dobrinska, C. Dujovne, D. E. Duggan, 1983, Clinical pharmacology and therapeutics.

Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin.

M. Mercuri, M. Dobrinska, J. Tobert, 1999, The American journal of cardiology.

The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day.

D R Illingworth, D. Hunninghake, D. Illingworth, 1997, The American journal of cardiology.

Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection.

B. Matuszewski, M. Dobrinska, J. Hsieh, 1995, Journal of chromatography. B, Biomedical applications.

3-HYDROXY-α-METHYLTYROSINE PROGENITORS, SYNTHESIS AND EVALUATION OF SOME (2-OXO-1,3-DIOXOL-4-YL)METHYL ESTERS

C. Sweet, W. S. Saari, S. Gaul, 1984 .

Calcium channel blocker-simvastatin interaction.

M. Dobrinska, J. Tobert, P. Gruer, 1999, Clinical pharmacology and therapeutics.

Use of In Vitro Drug Metabolism Data to Evaluate Metabolic Drug‐Drug Interactions in Man: The Need for Quantitative Databases

A. D. Rodrigues, M. Dobrinska, A D Rodrigues, 2001, Journal of clinical pharmacology.

Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies

Thomas Layloff, Vinod P. Shah, Kamal K. Midha, 1992, Pharmaceutical Research.

Pharmacokinetics of the pivaloyloxyethyl (POE) ester of methyldopa, a new prodrug of methyldopa

J. Bolognese, M. Dobrinska, W. Kukovetz, 1982, Journal of Pharmacokinetics and Biopharmaceutics.

Influence of Age and Gender on the Plasma Profiles of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitory Activity Following Multiple Doses of Lovastatin and Simvastatin

E. Stein, H. Quan, M. Dobrinska, 1992, Pharmaceutical Research.